Nobutaka Sakae1, Keith A Josephs2, Irene Litvan3, Melissa E Murray1, Ranjan Duara4, Ryan J Uitti5, Zbigniew K Wszolek5, Jay van Gerpen5, Neil R Graff-Radford5, Dennis W Dickson6. 1. Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA. 2. Department of Neurology, Mayo Clinic, Rochester, MN, USA. 3. Department of Neurology, University of California San Diego, La Jolla, CA, USA. 4. Mount Sinai Medical Center, Miami Beach, FL, USA. 5. Department of Neurology, Mayo Clinic, Jacksonville, FL, USA. 6. Department of Neuroscience, Mayo Clinic, Jacksonville, FL, USA. Electronic address: dickson.dennis@mayo.edu.
Abstract
INTRODUCTION: The corticobasal syndrome (CBS) is associated with several neuropathologic disorders, including corticobasal degeneration and Alzheimer's disease (AD). METHOD: In this report, we studied 43 AD patients with CBS (AD-CBS) and compared them with 42 AD patients with typical amnestic syndrome (AD-AS), as well as 15 cases of corticobasal degeneration and CBS pathology. RESULTS: Unlike AD-AS, AD-CBS had prominent motor problems, including limb apraxia (90%), myoclonus (81%), and gait disorders (70%). Alien limb phenomenon was reported in 26% and cortical sensory loss in 14%. Language problems were also more frequent in AD-CBS, and memory impairment was less frequent. AD-CBS had more tau pathology in perirolandic cortices but less in superior temporal cortex than AD-AS. In addition, AD-CBS had greater neuronal loss in the substantia nigra. DISCUSSION: AD-CBS is a clinicopathological subtype of AD with an atypical distribution of Alzheimer-type tau pathology. Greater neuronal loss in the substantia nigra may contribute to Parkinsonism which is not a feature of typical AD.
INTRODUCTION: The corticobasal syndrome (CBS) is associated with several neuropathologic disorders, including corticobasal degeneration and Alzheimer's disease (AD). METHOD: In this report, we studied 43 AD patients with CBS (AD-CBS) and compared them with 42 AD patients with typical amnestic syndrome (AD-AS), as well as 15 cases of corticobasal degeneration and CBS pathology. RESULTS: Unlike AD-AS, AD-CBS had prominent motor problems, including limb apraxia (90%), myoclonus (81%), and gait disorders (70%). Alien limb phenomenon was reported in 26% and cortical sensory loss in 14%. Language problems were also more frequent in AD-CBS, and memory impairment was less frequent. AD-CBS had more tau pathology in perirolandic cortices but less in superior temporal cortex than AD-AS. In addition, AD-CBS had greater neuronal loss in the substantia nigra. DISCUSSION: AD-CBS is a clinicopathological subtype of AD with an atypical distribution of Alzheimer-type tau pathology. Greater neuronal loss in the substantia nigra may contribute to Parkinsonism which is not a feature of typical AD.
Authors: Warren W Barker; Cheryl A Luis; Alice Kashuba; Mercy Luis; Dylan G Harwood; David Loewenstein; Carol Waters; Pat Jimison; Eugene Shepherd; Steven Sevush; Neil Graff-Radford; Douglas Newland; Murray Todd; Bayard Miller; Michael Gold; Kenneth Heilman; Leilani Doty; Ira Goodman; Bruce Robinson; Gary Pearl; Dennis Dickson; Ranjan Duara Journal: Alzheimer Dis Assoc Disord Date: 2002 Oct-Dec Impact factor: 2.703
Authors: Helen Ling; Gabor G Kovacs; Jean Paul G Vonsattel; Karen Davey; Kin Y Mok; John Hardy; Huw R Morris; Thomas T Warner; Janice L Holton; Tamas Revesz Journal: Brain Date: 2016-10-25 Impact factor: 13.501
Authors: Keith A Josephs; Jennifer L Whitwell; Bradley F Boeve; David S Knopman; Ronald C Petersen; William T Hu; Joseph E Parisi; Dennis W Dickson; Clifford R Jack Journal: Mov Disord Date: 2010-07-15 Impact factor: 10.338
Authors: Melissa J Armstrong; Irene Litvan; Anthony E Lang; Thomas H Bak; Kailash P Bhatia; Barbara Borroni; Adam L Boxer; Dennis W Dickson; Murray Grossman; Mark Hallett; Keith A Josephs; Andrew Kertesz; Suzee E Lee; Bruce L Miller; Stephen G Reich; David E Riley; Eduardo Tolosa; Alexander I Tröster; Marie Vidailhet; William J Weiner Journal: Neurology Date: 2013-01-29 Impact factor: 9.910
Authors: Adam L Boxer; Anthony E Lang; Murray Grossman; David S Knopman; Bruce L Miller; Lon S Schneider; Rachelle S Doody; Andrew Lees; Lawrence I Golbe; David R Williams; Jean-Cristophe Corvol; Albert Ludolph; David Burn; Stefan Lorenzl; Irene Litvan; Erik D Roberson; Günter U Höglinger; Mary Koestler; Clifford R Jack; Viviana Van Deerlin; Christopher Randolph; Iryna V Lobach; Hilary W Heuer; Illana Gozes; Lesley Parker; Steve Whitaker; Joe Hirman; Alistair J Stewart; Michael Gold; Bruce H Morimoto Journal: Lancet Neurol Date: 2014-05-27 Impact factor: 44.182
Authors: M L Gorno-Tempini; S M Brambati; V Ginex; J Ogar; N F Dronkers; A Marcone; D Perani; V Garibotto; S F Cappa; B L Miller Journal: Neurology Date: 2008-07-16 Impact factor: 9.910
Authors: Koji Kasanuki; Keith A Josephs; Tanis J Ferman; Melissa E Murray; Shunsuke Koga; Takuya Konno; Nobutaka Sakae; Adam Parks; Ryan J Uitti; Jay A Van Gerpen; Neill R Graff-Radford; Zbigniew K Wszolek; Dennis W Dickson Journal: Neurology Date: 2018-06-13 Impact factor: 9.910
Authors: Jonathan Graff-Radford; Keir X X Yong; Liana G Apostolova; Femke H Bouwman; Maria Carrillo; Bradford C Dickerson; Gil D Rabinovici; Jonathan M Schott; David T Jones; Melissa E Murray Journal: Lancet Neurol Date: 2021-03 Impact factor: 44.182
Authors: Nicolai Franzmeier; Matthias Brendel; Leonie Beyer; Luna Slemann; Gabor G Kovacs; Thomas Arzberger; Carolin Kurz; Gesine Respondek; Milica J Lukic; Davina Biel; Anna Rubinski; Lukas Frontzkowski; Selina Hummel; Andre Müller; Anika Finze; Carla Palleis; Emanuel Joseph; Endy Weidinger; Sabrina Katzdobler; Mengmeng Song; Gloria Biechele; Maike Kern; Maximilian Scheifele; Boris-Stephan Rauchmann; Robert Perneczky; Michael Rullman; Marianne Patt; Andreas Schildan; Henryk Barthel; Osama Sabri; Jost J Rumpf; Matthias L Schroeter; Joseph Classen; Victor Villemagne; John Seibyl; Andrew W Stephens; Edward B Lee; David G Coughlin; Armin Giese; Murray Grossman; Corey T McMillan; Ellen Gelpi; Laura Molina-Porcel; Yaroslau Compta; John C van Swieten; Laura Donker Laat; Claire Troakes; Safa Al-Sarraj; John L Robinson; Sharon X Xie; David J Irwin; Sigrun Roeber; Jochen Herms; Mikael Simons; Peter Bartenstein; Virginia M Lee; John Q Trojanowski; Johannes Levin; Günter Höglinger; Michael Ewers Journal: Nat Commun Date: 2022-03-15 Impact factor: 14.919
Authors: Daniel W Sirkis; Luke W Bonham; Taylor P Johnson; Renaud La Joie; Jennifer S Yokoyama Journal: Mol Psychiatry Date: 2022-04-07 Impact factor: 13.437
Authors: Piotr Alster; Natalia Madetko; Bartosz Migda; Michał Nieciecki; Michał Kutyłowski; Leszek Królicki; Andrzej Friedman Journal: Diagnostics (Basel) Date: 2022-07-09
Authors: Keith A Josephs; Nirubol Tosakulwong; Jonathan Graff-Radford; Stephen D Weigand; Marina Buciuc; Mary M Machulda; David T Jones; Christopher G Schwarz; Matthew L Senjem; Nilufer Ertekin-Taner; Kejal Kantarci; Bradley F Boeve; David S Knopman; Clifford R Jack; Ronald C Petersen; Val J Lowe; Jennifer L Whitwell Journal: Ann Clin Transl Neurol Date: 2020-04-15 Impact factor: 4.511